Literature DB >> 21765043

Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan.

C-H Tseng1.   

Abstract

BACKGROUND: The association between diabetes and non-Hodgkin's lymphoma (NHL) is rarely studied and the risk associated with insulin use is not known.
MATERIALS AND METHODS: The crude and age-standardized trends of NHL incidence in the general population from 1979 to 2007 were first calculated. NHL prevalence and annual incidence in 2005 were calculated in 329,198 insurants aged≥45 years from a random sample of 1,000,000 insurants of the National Health Insurance. The risk factors were evaluated using logistic regression.
RESULTS: NHL incidence trends increased significantly in either sex. A total of 1079 and 148 NHL cases were identified for prevalence and incidence analyses, respectively. The respective prevalence (per 100,000) for diabetic and nondiabetic subjects was 480.2 and 269.9 (P<0.01), and the respective incidence (per 100,000) was 70.9 and 35.3 (P<0.01). Odds ratio for diabetic versus nondiabetic subjects after adjustment for age, sex, occupation, and living region was 1.51 (95% confidence interval 1.33-1.71) for prevalence and 1.48 (1.06-2.06) for incidence. In diabetic patients, the adjusted odds ratio for insulin users versus nonusers was 1.63 (1.23-2.15) for prevalence and 2.52 (1.37-4.64) for incidence.
CONCLUSIONS: NHL incidence is increasing in Taiwan. Diabetes and insulin use are associated with a higher risk.

Entities:  

Mesh:

Year:  2011        PMID: 21765043     DOI: 10.1093/annonc/mdr334

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  14 in total

1.  Magnesium and lymphoma: opportunities in translation.

Authors:  S Van Laecke; E V Nagler; R Vanholder
Journal:  Leukemia       Date:  2014-04       Impact factor: 11.528

Review 2.  Diabetes and gastric cancer: the potential links.

Authors:  Chin-Hsiao Tseng; Farn-Hsuan Tseng
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

3.  Pioglitazone and bladder cancer: a population-based study of Taiwanese.

Authors:  Chin-Hsiao Tseng
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

Review 4.  A review on the association between glucagon-like peptide-1 receptor agonists and thyroid cancer.

Authors:  Wei-Yih Chiu; Shyang-Rong Shih; Chin-Hsiao Tseng
Journal:  Exp Diabetes Res       Date:  2012-05-28

Review 5.  Diabetes and thyroid cancer risk: literature review.

Authors:  Shyang-Rong Shih; Wei-Yih Chiu; Tien-Chun Chang; Chin-Hsiao Tseng
Journal:  Exp Diabetes Res       Date:  2012-06-12

Review 6.  Cancer biology in diabetes.

Authors:  Shi Sen; Yanzheng He; Daisuke Koya; Keizo Kanasaki
Journal:  J Diabetes Investig       Date:  2014-03-05       Impact factor: 4.232

7.  Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance.

Authors:  Chin-Hsiao Tseng
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

Review 8.  Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.

Authors:  Oystein Karlstad; Jacob Starup-Linde; Peter Vestergaard; Vidar Hjellvik; Marloes T Bazelier; Marjanka K Schmidt; Morten Andersen; Anssi Auvinen; Jari Haukka; Kari Furu; Frank de Vries; Marie L De Bruin
Journal:  Curr Drug Saf       Date:  2013-11

9.  Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study.

Authors:  Chin-Hsiao Tseng
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

10.  Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.

Authors:  Chin-Hsiao Tseng
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.